FBRX
NASDAQ
US
Forte Biosciences, Inc. - Common Stock
$25.58
▲ +$0.72
(+2.90%)
Vol 242K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$341.6M
ROE
-75.6%
Margin
-158775.0%
D/E
0.00
Beta
3.31
52W
$5–$31
Wall Street Consensus
12 analysts · Apr 20263
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
CABA
Cabaletta Bio Inc
$210.8M
XOMA
Xoma Royalty Corp
P/E 15.2
$329.3M
IRD
Opus Genetics Inc
$138.6M
XFOR
X4 Pharmaceuticals Inc
$349.7M
NGNE
Neurogene Inc
$319.1M
SRZN
Surrozen Inc
$193.7M
GLSI
Greenwich Lifesciences Inc
$291.1M
PALI
Palisade Bio Inc
$350.2M
CLYM
Climb Bio Inc
$272.7M
RZLT
Rezolute Inc
$218.8M
Earnings
Beat rate: 60.0%
Next Report
May 13, 2026
EPS Estimate: $-1.18
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.18 | — | — |
| Dec 2025 | $-1.24 | $-1.39 | $-0.15 |
| Sep 2025 | $-1.09 | $-0.99 | +$0.10 |
| Jun 2025 | $-1.13 | $-0.96 | +$0.17 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -85.4% | -85.4% | -85.4% | -85.4% | -85.4% | -75.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -158775.0% | -158775.0% | -158775.0% | -158775.0% | -158775.0% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 11.74 | 11.74 | 11.74 | 11.74 | 11.74 | 7.34 |
Key Ratios
ROA (TTM)
-65.9%
P/S (TTM)
8540.24
P/B
2.8
EPS (TTM)
$-4.49
CF/Share
$-0.86
Rev Growth 3Y
-7.2%
52W High
$31.27
52W Low
$4.90
$4.90
52-Week Range
$31.27
How does FBRX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
FBRX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8540.2
▲
66361%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.8
▲
12%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
FBRX profitability vs Biotechnology peers
ROE
-75.6%
▼
12%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-158775.0%
▼
55271%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-65.9%
▼
41%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
FBRX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
7.3
▲
65%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
3.3
▲
241%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
FBRX fundamentals radar
FBRX
Peer median
Industry
FBRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
FBRX vs peers: key metrics
Latest News
No related news yet